Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000253962 | SCV000317958 | uncertain significance | Cardiovascular phenotype | 2013-01-13 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Eurofins Ntd Llc |
RCV000725817 | SCV000339586 | uncertain significance | not provided | 2016-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725817 | SCV000515098 | likely benign | not provided | 2021-03-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23463027, 30764827, 27493940) |
CHEO Genetics Diagnostic Laboratory, |
RCV001798749 | SCV002042385 | uncertain significance | Cardiomyopathy | 2022-08-04 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000725817 | SCV001740895 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000725817 | SCV001798540 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000725817 | SCV001952034 | uncertain significance | not provided | no assertion criteria provided | clinical testing |